Cargando…
Expanding the Noonan spectrum/RASopathy NGS panel: Benefits of adding NF1 and SPRED1
BACKGROUND: RASopathies are a group of disorders caused by disruptions to the RAS‒MAPK pathway. Despite being in the same pathway, Neurofibromatosis Type 1 (NF1) and Legius syndrome (LS) typically present with phenotypes distinct from Noonan spectrum disorders (NSDs). However, some NF1/LS individual...
Autores principales: | Witkowski, Leora, Dillon, Mitchell W., Murphy, Elissa, S Lebo, Matthew, Mason‐Suares, Heather |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196473/ https://www.ncbi.nlm.nih.gov/pubmed/32107864 http://dx.doi.org/10.1002/mgg3.1180 |
Ejemplares similares
-
ClinGen’s RASopathy Expert Panel Consensus Methods for Variant Interpretation
por: Gelb, Bruce D., et al.
Publicado: (2018) -
Genotypic Findings in Noonan and Non-Noonan RASopathies and Patient Eligibility for Growth Hormone Treatment
por: Carcavilla, Atilano, et al.
Publicado: (2023) -
MEK inhibition ameliorates social behavior phenotypes in a Spred1 knockout mouse model for RASopathy disorders
por: Borrie, Sarah C., et al.
Publicado: (2021) -
Social skills in children with RASopathies: a comparison of Noonan syndrome and neurofibromatosis type 1
por: Pierpont, Elizabeth I., et al.
Publicado: (2018) -
Simultaneous Detection of NF1, SPRED1, LZTR1, and NF2 Gene Mutations by Targeted NGS in an Italian Cohort of Suspected NF1 Patients
por: Bianchessi, Donatella, et al.
Publicado: (2020)